Bulletin du Cancer
Volume 91, issue 5, Mai 2004
Volume 91, issue 5, Mai 2004
Gènes & Cancers
Gènes & Cancers
(p.393-4)
Brèves
Potentiel thérapeutique de drogues antagonistes de Mdm2
(p.395)
Philippe Jeanteur
Open Access
eIF‐4E : entre Akt et apoptose
(p.395-6)
Alain Jacquemin‐Sablon
Open Access
Thérapies anti‐EGFR : sursis ou sursaut ?
(p.395-6)
Stéphane Vignot
Open Access
Point sur
pRB, p53, p16
INK4a, senescence and malignant transformation
(p.399-402)
Christian‐Jacques Larsen
Synthèse
Management of emesis in cancer patients
(p.403-8)
Khemaies Slimane, Adriana Perez, Pierre Ruffié, Mario Di Palma
Update on docetaxel and breast cancer
(p.409-17)
Véronique Diéras, Véronique Girre, Jean‐Yves Pierga, Valérie Laurence, Sophie Piperno‐Neumann, Pierre Pouillart
SOR
2003 Clinical practice guideline: Standards, Options and Recommendations for pain assessment in adult and children with cancer (summary report)
(p.419-30)
Thierry Delorme, Chantal Wood, Anne Bataillard, Evelyne Pichard, Sarah Dauchy, Daniel Orbach, Jean‐Pierre Alibeu, Christine Ricard, Agnès Suc, François Boureau, Sophie Rousmans, Régis Patte
Article original
Complications thrombotiques des chambres à cathéter implantables : évaluation prospective
(p.431-6)
Jean‐Luc Labourey, Philippe Lacroix, Dominique Genet, François Gobeaux, Jean Martin, Laurence Venat‐Bouvet, Sandrine Lavau‐Denes, Antoine Maubon, Nicole Tubiana‐Mathieu
Anticancer drugs use evaluation: limits of the approved labeling
(p.437-43)
Isabelle Debrix, Thierry André, Antoine Flahault, Ogbe Kalu, Joseph Gligorov, Jean‐Pierre Lotz, Bernard Milleron, Françoise Pene, Yasmine Boukari, Annie Becker
A prospective evaluation of antibiotic prophylaxis efficacy for breast cancer surgery following previous chemotherapy
(p.445-8)
Nicolas Penel, Charles Fournier, Sylvia Giard, Danièle Lefebvre
For a coordination of the supportive care for people affected by severe illnesses: proposition of organization in the public and private health care centres
(p.449-56)
Ivan Krakowski, François Boureau, Roland Bugat, Laurent Chassignol, Philippe Colombat, Laure Copel, Daniel d’Hérouville, Marylène Filbet, Bernard Laurent, Nadine Memran, Jacques Meynadier, Gérard Parmentier, Philippe Poulain, Pierre Saltel, Daniel Serin, Jean‐Philippe Wagner
Compte rendu de congrès
Prévention du cancer
(p.457-9)
Gilles L’Allemain
Electronic journal of oncology
Gefitinib (Iressa, ZD1839): a novel targeted approach for the treatment of solid tumors
(p.10070-6)
Joachim VON PAWEL
Cytokine levels in bronchoalveolar lavage fluid and blood of neutropenic patients with pneumonia
(p.10077-80)
B. Allaouchiche, B. Coronel, M. C. Gagnieu, D. Chassard, A. Mercatello
Resistance to Microtubule-Targeted Cytotoxins in a K562 Leukemia Cell Variant Associated with Altered Tubulin Expression and Polymerization
(p.10081-112)
Charles Dumontet, Jean-Pierre Jaffrezou, Etsuko Tsuchiya, George E. Duran, Gang Chen, W. Brent Derry, Leslie Wilson, Mary Ann Jordan, Branimir I. Sikic
Treatment of peritoneal carcinomatosis in patients with digestive cancers with combination of intraperitoneal hyperthermia and mitomycin C
(p.10113-32)
Annie c. Sayag-Beaujard, Yves Francois, Olivier Glehen, Babak Sadeghi-Looyeh, Jacques Bienvenu, Gilles Panteix, Florence Garbit, Eric Grandclément, Vincent Banssillon, Jacques Vignal, Francois N. Gilly
Ceramide : A New Target in Anticancer Research?
(p.10133-61)
Jean-Pierre Jaffrezou, Guy Laurent